180 related articles for article (PubMed ID: 25366875)
1. Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.
Rouine J; Kelly ME; Jennings-Murphy C; Duffy P; Gorman I; Gormley S; Kerskens CM; Harkin A
Psychopharmacology (Berl); 2015 May; 232(9):1501-13. PubMed ID: 25366875
[TBL] [Abstract][Full Text] [Related]
2. MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI.
Rouine J; Gobbo OL; Campbell M; Gigliucci V; Ogden I; McHugh Smith K; Duffy P; Behan B; Byrne D; Kelly ME; Blau CW; Kerskens CM; Harkin A
Br J Pharmacol; 2013 Jul; 169(5):974-87. PubMed ID: 23517012
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
Jones K; Brennan KA; Colussi-Mas J; Schenk S
Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
[TBL] [Abstract][Full Text] [Related]
4. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Saadat KS; O'shea E; Colado MI; Elliott JM; Green AR
Psychopharmacology (Berl); 2005 Jun; 179(4):884-90. PubMed ID: 15650843
[TBL] [Abstract][Full Text] [Related]
5. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
Fantegrossi WE; Kiessel CL; De la Garza R; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):529-36. PubMed ID: 15983787
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment.
Moyano S; Frechilla D; Del Río J
Psychopharmacology (Berl); 2004 May; 173(3-4):337-45. PubMed ID: 14985918
[TBL] [Abstract][Full Text] [Related]
7. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
Ramos M; Goñi-Allo B; Aguirre N
Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
[TBL] [Abstract][Full Text] [Related]
8. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
9. Influence of PCPA and MDMA (ecstasy) on physiology, development and behavior in Drosophila melanogaster.
Dasari S; Viele K; Turner AC; Cooper RL
Eur J Neurosci; 2007 Jul; 26(2):424-38. PubMed ID: 17650115
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.
Gudelsky GA; Yamamoto BK; Nash JF
Eur J Pharmacol; 1994 Nov; 264(3):325-30. PubMed ID: 7698172
[TBL] [Abstract][Full Text] [Related]
12. The effect of 3,4-methylenedioxymethamphetamine ('Ecstasy') on serotonergic regulation of the mammalian circadian clock mechanism in rats: the role of dopamine and hyperthermia.
Dafters RI; Biello SM
Neurosci Lett; 2003 Oct; 350(2):117-21. PubMed ID: 12972167
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Darvesh AS; Yamamoto BK; Gudelsky GA
J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
[TBL] [Abstract][Full Text] [Related]
14. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
Ball KT; Rebec GV
Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.
Vanattou-Saïfoudine N; McNamara R; Harkin A
Br J Pharmacol; 2010 Jun; 160(4):860-77. PubMed ID: 20590585
[TBL] [Abstract][Full Text] [Related]
16. 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation.
Shirayama Y; Hashimoto K; Iyo M; Watanabe K; Higuchi T; Minabe Y
Eur J Pharmacol; 2000 Aug; 402(3):215-22. PubMed ID: 10958887
[TBL] [Abstract][Full Text] [Related]
17. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
García-Osta A; Del Río J; Frechilla D
Brain Res Mol Brain Res; 2004 Jul; 126(2):181-7. PubMed ID: 15249142
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats.
Schenk S; Gittings D; Colussi-Mas J
Br J Pharmacol; 2011 Apr; 162(8):1770-80. PubMed ID: 21198550
[TBL] [Abstract][Full Text] [Related]
19. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.
Bull EJ; Hutson PH; Fone KC
Neuropharmacology; 2004 Feb; 46(2):202-10. PubMed ID: 14680758
[TBL] [Abstract][Full Text] [Related]
20. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
Nash JF; Meltzer HY; Gudelsky GA
J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
